Portrait der Gilead Sciences Aktie
Das Unternehmen Gilead Sciences aus USA ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.
Gilead Sciences ist in mehr als 83 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares Nasdaq US Biotechnology UCITS ETF gewichtet Gilead Sciences mit 7,06% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Gilead Sciences Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Gilead Sciences am höchsten gewichtet ist Insgesamt in 83 ETFs enthalten
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
325 News & Informationen zur Gilead Sciences Aktie
The Worldwide DNA Vaccines Industry Should Reach $11.5 Billion By 2026
DUBLIN, Sept. 1, 2021 /PRNewswire/ — The
Galapagos Says New CEO Will Have Strong Science Background
GuruFocus Article or News written by Barry Cohen and the topic is about: Founder and CEO van de Stope leaving after several R&D misses
Global Respiratory Syncytial Virus Market 2021: Strong Product Pipeline is Expected to Support Growth – Forecast to 2027
/PRNewswire/ — The “Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form (Oral, Other), By…
Global Respiratory Syncytial Virus Market 2021: Strong Product Pipeline Is Expected To Support Growth – Forecast To 2027
DUBLIN, Aug. 31, 2021 /PRNewswire/ — The “Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form
4 Coronavirus Stocks That Are Still Worth Buying By StockNews
4 Coronavirus Stocks That Are Still Worth Buying
Agenus is a Speculative Trade Worth the Risk
Angenus (AGEN) is a biotech company focused on clinical-stage immuno-oncology, with 17 candidates in development. Nine of those candidates are company
Ziopharm Oncology : Appoints Kevin S. Boyle, Sr., as Chief Executive Officer and Announces other Executive Promotions (Form 8-K)
Ziopharm Oncology Appoints Kevin S. Boyle, Sr., as Chief Executive Officer and Announces other Executive Promotions
Mr. Boyle brings over 20 years of executive… | August 30, 2021
Ligand Pharmaceuticals Incorporated : Partner Gloria Biosciences Receives Approval in China for Zimberelimab for the Treatment of Recurrent or Refractory Classical Hodgkin's Lymphoma
First regulatory approval of an OmniAb-derived antibody
… | August 30, 2021
Biotech Startup Backed by Moderna Creator Raises $440 Million
(Bloomberg) — Laronde, a biotech startup backed by the venture firm that helped create Moderna Inc., raised $440 million in a financing round to develop new…
Former shoe store owner barred from running business in bias settlement
As Kendall Square building and Apple's CEO reap huge payoffs, supply chain woes have golfers grumbling.
Pfizer's Covid Technology May Have Cancer Applications
GuruFocus Article or News written by Barry Cohen and the topic is about: The mRNA-produced vaccines are now being tested in lung and breast cancers
Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement
Shares of Aadi to commence trading on the Nasdaq Capital Market on August 27, 2021 under ticker symbol “AADI”Concurrent $155 million PIPE financing is…
Startup Pardes Biosciences Joins Hunt for Covid-19 Pill
The company is competing with drugmakers including Pfizer and Shionogi to create a Covid-19 medicine that can be used outside the hospital.
Greatmark Investment Partners, Inc. Buys Discovery Inc, Amgen Inc, The Travelers Inc, Sells Coherent Inc, Gilead Sciences Inc, Teva Pharmaceutical Industries
GuruFocus Article or News written by insider and the topic is about:
Pulmonary Arterial Hypertension Market revenue to cross USD 10.1 Bn by 2027: Global Market Insights Inc.
Brazil pulmonary arterial hypertension market will account for USD 125 million by 2027 due to the growing supportive government initiatives for promoting…
Robertson Stephens Wealth Management, LLC Buys Acuity Brands Inc, Stance Equity ESG Large Cap Core ETF, PowerShares QQQ Trust Ser 1, Sells Vanguard Dividend Appreciation FTF, BTC iShares Core MSCI EAF
GuruFocus Article or News written by insider and the topic is about:
Haverford Trust Co Buys Texas Instruments Inc, iShares TIPS Bond ETF, McCormick Inc, Sells Boyd Gaming Corp, GlaxoSmithKline PLC, BTC BlackRock Short Maturity Bond ETF
GuruFocus Article or News written by insider and the topic is about:
PFM Health Sciences, LP Buys Seagen Inc, Centene Corp, ACADIA Pharmaceuticals Inc, Sells PPD Inc, Jaws Acquisition Corp, Insulet Corp
GuruFocus Article or News written by insider and the topic is about:
Galapagos engagiert Director Communications & Public Affairs
Die Website new-business.de hält die Medien- und Kommunikationsszene täglich auf dem Laufenden. Von Montag bis Freitag versorgen zweimal täglich die mittag news und abend news die Community mit Nachrichten.
Holocene Advisors, LP Buys Farfetch, Salesforce.com Inc, DoorDash Inc, Sells Microsoft Corp, Facebook Inc, NVIDIA Corp
GuruFocus Article or News written by insider and the topic is about:
Rákgyógyszert fejlesztő céget vett a Pfizer
Legyen az elsők között, akik a postaládájukba kapják a világhírű üzleti magazint. A Forbes magyar nyelvű kiadása havonta jelenik meg, minden hónap első csütörtökén kerül az újságosstandokra.
Pfizer to buy Canadian drug developer Trillium Therapeutics for $2.2B
Pfizer Inc. said on Monday it would buy Canadian drug developer Trillium Therapeutics Inc. in a $2.26 billion deal to strengthen its arsenal of blood cancer therapies.
Vaxart Announces Highly Regarded Biotech Executive Julie M. Cherrington, Ph.D., Joins Board Of Directors
SOUTH SAN FRANCISCO, Calif., Aug. 23, 2021 /PRNewswire/ — Vaxart, Inc. VXRT today announced the addition of Julie M. Cherrington, Ph.D., to the company's
Provident Investment Management, Inc. Buys Vertex Pharmaceuticals Inc, CarGurus Inc, Vimeo Inc, Sells Match Group Inc, TCF Financial Corp, Synnex Corp
GuruFocus Article or News written by insider and the topic is about:
Factbox-Major U.S. companies making masks, vaccines mandatory
The resurgence of COVID-19 cases in the United States due to the Delta variant and the new guidance from the U.S. Centers for Disease Control and Prevention that requires fully vaccinated… | August 20, 2021
Parnassus Investments Buys Nike Inc, Alphabet Inc, Gilead Sciences Inc, Sells Amazon.com Inc, Micron Technology Inc, Deere
GuruFocus Article or News written by insider and the topic is about:
Legato Capital Management LLC Buys iShares MSCI EAFE ETF, CVS Health Corp, Goldman Sachs Group Inc, Sells Bryn Mawr Bank Corp, HDFC Bank, Gilead Sciences Inc
GuruFocus Article or News written by insider and the topic is about:
Vaxart Announces Creation of New Scientific and Clinical Advisory Board
SOUTH SAN FRANCISCO, Calif., Aug. 19, 2021 /PRNewswire/ — Vaxart, Inc. (NASDAQ: VXRT), today announced the creation of an eight-member Scientific…
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET on Wednesday, 77 companies hit new 52-week highs.
Areas of Significance: Pfizer (NYSE:PFE) was the largest firm on a market …
Pulmonary Arterial Hypertension Market Size Worth $7.7 Billion By 2028: Grand View Research, Inc.
/PRNewswire/ — The global pulmonary arterial hypertension market size is expected to reach USD 7.7 billion by 2028, according to a new report by Grand View…
Pulmonary Arterial Hypertension Market Size Worth $7.7 Billion By 2028: Grand View Research, Inc.
SAN FRANCISCO, Aug. 18, 2021 /PRNewswire/ — The global pulmonary arterial hypertension market size is expected to reach USD 7.7 billion by 2028, …
DHUnplugged #569: Cold Water
10 Healthcare Dividend Stocks Hedge Funds are Buying
In this article, we will be looking at the 10 healthcare dividend stocks that hedge funds are buying.
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs.
Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market …
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc. (NYSE: BIO) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Gilead Sciences, Inc. (NASDAQ: GILD) GlaxoSmithKline plc (NYSE: GSK) Johnson & Johnson (NYSE: JNJ) Laboratory Corporation of America Holdings (NYSE: LH) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) NanoVibronix, Inc. (NASDAQ: NAOV) (announced intention to enter over-
Royalty Pharma Is a Stock Worth Crowning
Investors who want exposure to biotech without taking the biggest drug development risks are in luck.
Gritstone And CEPI Announce Agreement To Advance Second-Generation COVID-19 Vaccine Program (CORAL) Against SARS-CoV-2 Variants Of Concern
CEPI to fund Gritstone's work on second-generation vaccines against SARS-CoV-2, the virus causing COVID-19, including a clinical trial in South Africa and
Point72 Asset Management Buys Salesforce.com Inc, Amazon.com Inc, Analog Devices Inc, Sells Applied Materials Inc, DXC Technology Co, Baidu Inc
GuruFocus Article or News written by insider and the topic is about:
Ligand Pharmaceuticals Incorporated : Partner Travere Therapeutics Announces Positive Topline Interim Results from the Ongoing Phase 3 PROTECT Study of Sparsentan in IgA Nephropathy
Sparsentan treatment demonstrated a statistically significant mean reduction of proteinuria from baseline after 36 weeks, more than threefold the reduction of active comparator irbesartan… | August 16, 2021
Stocks That Hit 52-Week Highs On Monday
Before 10 a.m. ET on Monday, 71 companies hit new 52-week highs.
Highlights: Apple (NASDAQ:AAPL) was the largest firm on a market cap basis to …